Yüklüyor......
The risky reliance on small surrogate endpoint studies when planning a large prevention trial
The definitive evaluation of treatment to prevent a chronic disease with low incidence in middle age, such as cancer or cardiovascular disease, requires a trial with a large sample size of perhaps 20,000 or more. To help decide whether to implement a large true endpoint trial, investigators first ty...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3616635/ https://ncbi.nlm.nih.gov/pubmed/23565041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1467-985X.2012.01052.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|